Omni 1000 Grant Opportunity in High Plex Proteomics

Grant Competition

Nomic Bio is thrilled to announce an exciting funding opportunity for proteomics with its groundbreaking Nomic Omni 1000, that leverages carefully designed, proteome- wide content and the advanced nELISA® technology. We invite researchers, innovators, and consortia to submit proposals that explore novel applications of high-throughput proteomics in drug discovery, biomarker development, or other relevant fields.

Who Should Apply?

This grant is open to researchers, academic institutions, biotech startups, and industry partners looking to integrate cutting-edge proteomics technologies into their work. Applicants should have a strong scientific rationale and a clear plan for utilizing Nomic Omni 1000.

What We Offer

We're excited to offer multiple Nomic Omni 1000 grants to profile samples for human plasma, serum, or in vitro human cell supernatant.

Grant details (for each winner):

• Profiling Service: Nomic Omni 1000
• Sample Number: Up to 1,152 samples (run as a single study)
• Reagents and Service: Provided by Nomic Bio
• Analysis and Support: Full access to Nomic Data Portal, expert technical support, and consultation throughout your project
• Sample Submission: All samples must be submitted to Nomic Bio within the 2025 calendar year

Sample Type (select one per application):

• in vitro supernatant of human cells
  
  or
• Human plasma or serum

Application Process

Interested applicants should submit a 250 word (not including title, authors, or affiliations) proposal outlining:

• Project title and objectives
• Research plan and expected outcomes
• Relevance to proteomics and potential impact

Proposals will be evaluated based on scientific merit, innovation, feasibility, and alignment with Nomic Bio’s mission.

How to Apply

Submit your application via the form at right by June 30th, 2025.

Take advantage of this unique opportunity to advance your research with Nomic’s Omni 1000 and state-of-the-art nELISA proteomics technology!

Terms and Conditions Apply.